Lamotrigine
Product Images NDC 68071-2974

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68071-2974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2974 9)

Label for Lamotrigine 25 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 90 tablets. It describes the tablet as round, flat, beveled-edged, white to off-white with a bisect and debossed logo "ZC" and "79" on one side. The label also includes the NDC 68071-2974-9, manufacturer details, storage instructions, and a warning to keep out of reach of children.*

FDA Label Image

Image (9386cb5f Ece0 47fd 82b5 8c80475a7094 388 2)

Lamotrigine tablet imprinted with 'ZC' over '79'. This imprint identifies the round oral tablet form of Lamotrigine by NuCare Pharmaceuticals, Inc., NDC 68071-2974.*

FDA Label Image

Image (9386cb5f Ece0 47fd 82b5 8c80475a7094 388 3)

The image shows a round, white tablet scored with a horizontal line. The tablet is marked with "ZC" above the score and "80" below, indicating an 80 mg strength. This Lamotrigine tablet is produced by NuCare Pharmaceuticals, Inc.*

FDA Label Image

Image (9386cb5f Ece0 47fd 82b5 8c80475a7094 388 4)

Lamotrigine 81 mg round white tablet with a bisecting score line, imprinted on one side with 'ZC' above the score line and '81' below. Labeler is NuCare Pharmaceuticals, Inc.*

FDA Label Image

Image (9386cb5f Ece0 47fd 82b5 8c80475a7094 388 5)

Lamotrigine tablet imprinted with 'ZC' above a score line and '82' below. The round, white tablet's imprint identifies it as a Lamotrigine product from NuCare Pharmaceuticals, Inc.*

FDA Label Image

Structured Formula For Lamotrigine (F432b9ab B725 40f4 A1c4 2b0d198dec28 01)

Chemical structure of lamotrigine, showing a triazine ring with amino groups and a chlorinated phenyl ring.*

FDA Label Image

Lamotrigine Tablet (F432b9ab B725 40f4 A1c4 2b0d198dec28 02)

A Kaplan-Meier failure probability curve comparing Lamotrigine to placebo over a time period up to 100 weeks. The Y-axis shows failure probability percentage from 0 to 100%, and the X-axis shows weeks from 0 to 100. Two lines represent Lamotrigine and placebo groups, with censoring marks indicated.*

FDA Label Image

Lamotrigine Tablets (F432b9ab B725 40f4 A1c4 2b0d198dec28 03)

A line chart depicting failure probability (%) over weeks for Lamotrigine compared to placebo. The graph shows two curves labeled 'Lamotrigine' and 'Placebo,' with failure probability increasing over time for both. Censored data points are marked along the curves. The y-axis ranges from 0 to 100%, and the x-axis spans approximately 0 to 80 weeks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.